Douglas W. Scharre
Papers
1
Total Citations
2
H-Index
1
About
Douglas W. Scharre is a leading neurologist and researcher whose work centers on the diagnosis, treatment, and care of Alzheimer’s disease and other dementias. He has made pioneering contributions to cognitive assessment, most notably through the development of the Self-Administered Gerocognitive Examination (SAGE), a widely used, validated tool for early detection of cognitive impairment. Scharre’s research also explores innovative interventions for dementia patients, including a multi-site randomized clinical trial of socially assistive robots to engage older adults with cognitive impairment in long-term care settings. His work bridges clinical practice and technology, aiming to improve quality of life and functional outcomes. With over 100 peer-reviewed publications and thousands of citations, Scharre’s impact is evident in the global adoption of the SAGE test and his leadership in cognitive neurology at The Ohio State University Wexner Medical Center. He is a sought-after speaker and educator, dedicated to advancing dementia care through both pharmacological and non-pharmacological approaches.
Research Focus
Key Achievements
Top Papers
- 1